Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2251 AL 2265

Artificial intelligence and machine learning in neurodegenerative disease management: A 21st century paradigm

Basha S, Ks P, Chattopadhyay A, Pai AR, Mahato KK.

Neurobiol Dis. 2026 Mar;220:107307. doi: 10.1016/j.nbd.2026.107307. Epub 2026 Feb 3.

Eye tracking as a digital biomarker in neurodegenerative diseases

Giacomini PS, Voss P, Devonshire V, Schneider R, Macaron G, Hussein S, Blanchette F, de Villers-Sidani É.

J Neurol. 2026 Feb 10;273(2):133. doi: 10.1007/s00415-026-13666-8.

Rosemary (Rosmarinus officinalis L.) and nervous system disorders: New findings on its neuroprotective properties

Vafadar Moradi E, Rezvani Kakhki B, Yazdanpanah Z, Jalali J, Ghasemzadeh Rahbardar M.

Iran J Basic Med Sci. 2026;29(2):155-180. doi: 10.22038/ijbms.2025.88710.19158.

Gut-Brain Signaling in Parkinson's Disease: A Narrative Review

Ratajczyk K, Kaczorowska E, Wyka K, Tarasiuk-Zawadzka A, Fichna J, Gajos A.

Int J Mol Sci. 2026 Apr 15;27(8):3531. doi: 10.3390/ijms27083531.

Insulin in brain: The physiological functions and therapeutic insights for neurodegenerative diseases

Shang X, Chen SY, Zhang XY, Regina I, Zhang T, Luo J, Yan YZ, Qiao-yuanYao, Tong F, Pan LH.

Life Sci. 2026 Aug 1;398:124468. doi: 10.1016/j.lfs.2026.124468. Epub 2026 May 15.

Lithium as a disease-modifying therapy for Parkinson's disease: mechanisms, preclinical evidence, and clinical prospects

Boonstra JT.

Clin Park Relat Disord. 2026 Apr 9;14:100440. doi: 10.1016/j.prdoa.2026.100440. eCollection 2026.

Therapeutic and Diagnostic Implications of Carbon Dot: An Advancement in the Avenue towards Cancer, Diabetes and Neurodegenerative Disorders

Manna S, Banerjee S, De A, Banerjee S, Das S, Rakshit P, S K AK, Sen KK, De S.

Pharm Nanotechnol. 2026;14(1):94-121. doi: 10.2174/0122117385314533240824090949.

Machine learning to diagnose, classify and predict phenoconversion in isolated REM sleep behavior disorder

Raheel K, Sheybani L, Biabani N, Rui SQ, Delogu A, Rosenzweig J, Cvetkovic Z, Leech R, Grossman N, Tahmasian M, Goadsby PJ, Chaudhuri KR, Schenck CH, Rosenzweig I.

Sleep Med Rev. 2026 Apr 29;88:102298. doi: 10.1016/j.smrv.2026.102298. Online ahead of print.

Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects

Dong S, Lu J, Wu L, Wang S, Gong Y, Hu J, Liu Y, Chen X.

Int Immunopharmacol. 2026 Aug 1;182:116780. doi: 10.1016/j.intimp.2026.116780. Epub 2026 May 6.

Parkinson's through a cultural lens: Diversity in disease expression and care

Morales-Briceno H, Chen KS, Becker P, Williams L, Paramanandam V, Toh TS, Ojo O, Sassi SB, Aldaajani Z, Tan AH.

J Parkinsons Dis. 2026 May 12:1877718X261440706. doi: 10.1177/1877718X261440706. Online ahead of print.

PINK1/Parkin-dependent mitophagy mediates astrocytic inflammatory responses to mitochondrial damage

Riley JF, Robbins CV, Holzbaur ELF.

bioRxiv [Preprint]. 2026 May 13:2026.05.11.724378. doi: 10.64898/2026.05.11.724378.

The Microbiota-Gut-Brain Axis Across the Lifespan: From Neurodevelopment to Neurodegeneration

Carnazzo SM, Fanos V.

J Clin Med. 2026 Apr 17;15(8):3065. doi: 10.3390/jcm15083065.

Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease

Foltynie T, Gandhi S, Carroll C.

J Parkinsons Dis. 2026 Feb 8:1877718X261420002. doi: 10.1177/1877718X261420002. Online ahead of print.

Cueing-assisted gamified augmented-reality home rehabilitation for gait and balance in people with Parkinson disease: feasibility and effectiveness in the clinical pathway

Hoogendoorn EM, Geerse DJ, van Dam AT, van Hall SJ, van Doorn PF, Hardeman LES, Hoozemans MJM, Stins JF, Roerdink M.

Phys Ther. 2026 Mar 3;106(3):pzag012. doi: 10.1093/ptj/pzag012.

Flavonoids improve neurotransmitters for Parkinson's treatment: mechanism and therapeutic potential

Zhang Y, Bu Y, Song M, Hao Z, Chen J.

Front Pharmacol. 2026 Apr 9;17:1799142. doi: 10.3389/fphar.2026.1799142. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias